Today's Veterinary Business

OCT 2018

Today’s Veterinary Business provides information and resources designed to help veterinarians and office management improve the financial performance of their practices, allowing them to increase the level of patient care and client service.

Issue link:

Contents of this Issue


Page 3 of 67

Delivering depth WG Critical Care Animal Health's product portfolio – and its distribution capabilities for those products – is expanding. Known for its products in the dairy market, WG Critical Care has been undergoing an expansion of sorts recently. The company is putting the final touches on a new high-tech distribution facility, for instance. But there is also a significant diversification happening with WG Critical Care's product port- folio, bringing the company into new markets. And the diversification is happening through a process of integration. Meeting a need One of the product segments added to the portfolio is derived from a part- nership with Infomed Fluids, a global health care company that specializes in lifesaving drugs and technologies for infusion and clinical nutrition. Founded in 2004, Infomed manufactures a comprehensive range of IV generic drugs, infusion therapies and clinical nutritional products. Infomed's quality man- agement systems ensure compliance with national and international legal, regulatory and standards requirements (ISO 9001, EMEA, FDA) and are regu- larly audited and certified by external auditors. Through its partnership with WG Critical Care Animal Health, which began in 2015, Infomed's immense manufacturing capacity will help ease shortages of IV solutions impacting the U.S. veterinary industry. Large animal practitioners in particular have had to deal with fluid shortages in recent years. At present, Infomed's FDA-inspected site has been permitted to export into the United States. Such products include: • Lactated Ringer Injection • Veterinary Plasmalyte pH 7.4 injection • 0.9% Sodium Chloride injection • 5% Dextrose The addition of the Infomed line of IV solutions has added great depth to WG Critical Care's portfolio. Diversification into the companion animal therapy market has been facilitated by the various doses available from Infomed: 500 ml, 1000 ml, 3,000 ml and 5,000 ml. Closer to the supply chain WG Critical Care has also made a significant investment in its distribution capabilities. Its new state-of-the-art distribution facility in Hamilton, New York, will become fully operational in late Q3 of 2018, and move products closer to supply chain partners. QUARTERMASTER and Ampicillin Trihy- drate will be distributed out of Hamilton, along with go-dry, MASTI-CLEAR and 1-gram equine U.S. VET Ampicillin Sodium. The QUARTERMASTER manufacturing site is less than a mile away from the new distribution facility, and other products are manufactured in Syracuse, New York, only 40 miles from the new site. The new facility will also implement the latest in ERP and track and trace software, climate control systems and auxiliary power. WG Critical Care promises more to come, including two new prod- ucts under development with an eye toward late 2019 launch dates. • 0.9% Sodium Chloride • 5% Dextrose Injection • Ampicillin for Injectable Suspension, Veterinary • Ampicillin Sodium • go-dry • Lactated Ringer's Injection, USP • MASTI-CLEAR • PLASMA-LYTE A Injection • QUARTERMASTER Suspension For more information, visit WG Critical Care Animal Health portfolio of products 2 Today's Veterinary Business Sponsored Sponsored Content from WG Critical Care

Articles in this issue

Links on this page

Archives of this issue

view archives of Today's Veterinary Business - OCT 2018